Biopharma Daily Stock Updates - 01/05/21

$XBI -0.35% 📉

COVID:

$CERC (+10.61%) - Cerecor Announces Successful Proof of Concept Data for CERC-002, a Unique LIGHT-Neutralizing Antibody, in Patients Hospitalized with COVID-19 ARDS

https://ir.cerecor.com/press-releases/detail/114

$MRNA (-2.28%) - Israeli Ministry of Health Authorizes COVID-19 Vaccine Moderna for Use in Israel

https://investors.modernatx.com/news-releases/news-release-details/israeli-ministry-health-authorizes-covid-19-vaccine-moderna-use

PIPELINE:

$RGNX (-0.13%) - RGX-314 update & RGX-202 announcement

http://ir.regenxbio.com/news-releases/news-release-details/regenxbio-announces-update-rgx-314-and-pivotal-program-treatment

$PGEN (-12.60%) - Precigen Announces Clearance of IND to Initiate Phase I Study of PRGN-2012 AdenoVerse™ Immunotherapy in Patients with Recurrent Respiratory Papillomatosis (RRP)

https://investors.precigen.com/news-releases/news-release-details/precigen-announces-clearance-ind-initiate-phase-i-study-prgn

$MYOV (-3.10%) - Myovant Sciences Announces U.S. Availability of ORGOVYX™ for the Treatment of Advanced Prostate Cancer

https://investors.myovant.com/news-releases/news-release-details/myovant-sciences-announces-us-availability-orgovyxtm-treatment

FINANCIALS:

$RYTM (+3.82%) - Rhythm Pharmaceuticals Announces Sale of Priority Review Voucher for $100M

https://ir.rhythmtx.com/news-releases/news-release-details/rhythm-pharmaceuticals-announces-sale-priority-review-voucher